Immunology and genetic of preeclampsia
2006

Immunology and Genetics of Preeclampsia

Sample size: 1188207 publication 10 minutes Evidence: moderate

Author Information

Author(s): NORMA C. SERRANO

Primary Institution: Biomedical Research Centre, Universidad Autonoma de Bucaramanga (UNAB), Bucaramanga, Colombia

Hypothesis

The study investigates the immunogenetic factors contributing to the development of preeclampsia.

Conclusion

Preeclampsia is a complex disorder influenced by immunogenetic factors leading to inadequate placentation.

Supporting Evidence

  • Preeclampsia occurs in around 5% of all pregnancies and is a major cause of maternal and fetal mortality.
  • Genetic factors contribute significantly to the risk of developing preeclampsia, with heritability estimated at 54%.
  • Certain cytokine imbalances have been linked to the pathophysiology of preeclampsia.

Takeaway

Preeclampsia is a serious condition during pregnancy caused by problems with how the placenta grows, and it can be influenced by genetics.

Methodology

The study involved systematic reviews and analysis of genetic associations in various populations.

Potential Biases

Potential biases may arise from the observational nature of the studies and genetic variability among populations.

Limitations

The results regarding genetic associations have not been consistently reproducible across different studies.

Participant Demographics

The study included women from various ethnic backgrounds, including white and African-American populations.

Statistical Information

P-Value

0.001

Confidence Interval

95%CI 9-45

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1080/17402520600876903

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication